Resultats a la cerca d'autor

1

Carregant...

COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION

per D. V. Nebieridze
Publicat 2016-01-01

Obtenir text complet

Artigo

2

Carregant...

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

per D. V. Nebieridze
Publicat 2015-12-01

Obtenir text complet

Artigo

3

Carregant...

CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS

per D. V. Nebieridze
Publicat 2015-12-01

Obtenir text complet

Artigo

4

Carregant...

Hyperuricemia a New Cardiovascular Risk Factor

per D. V. Nebieridze
Publicat 2020-03-01

Obtenir text complet

Artigo

5

Carregant...

Topical issues of beta-blockers use in various clinical situations

per D. V. Nebieridze
Publicat 2018-07-01

Obtenir text complet

Artigo

6

Carregant...

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS

per D. V. Nebieridze
Publicat 2002-02-01

Obtenir text complet

Artigo

7

Carregant...

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»

per D. V. Nebieridze
Publicat 2015-12-01

Obtenir text complet

Artigo

8

Carregant...

Topical questions of beta-blockers application in clinical practice

per D V Nebieridze
Publicat 2014-12-01

Obtenir text complet

Artigo

9

Carregant...

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?

per D. V. Nebieridze, A. S. Safarian
Publicat 2016-01-01

Obtenir text complet

Artigo

10

Carregant...

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

per D. V. Nebieridze, T. V. Kamyshova
Publicat 2015-12-01

Obtenir text complet

Artigo

11

Carregant...

Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part II

per A. S. Safaryan, D. V. Nebieridze
Publicat 2021-10-01

Obtenir text complet

Artigo

12

Carregant...

New potential of ACE inhibitors in clinical practice

per D. V. Nebieridze, A. S. Safaryan
Publicat 2010-10-01

Obtenir text complet

Artigo

13

Carregant...

High-risk patients: modern treatment strategy

per D. V. Nebieridze, A. Meliya
Publicat 2010-12-01

Obtenir text complet

Artigo

14

Carregant...

Place of imidazoline receptor agonists in the treatment of hypertension

per D. V. Nebieridze, A. S. Safaryan
Publicat 2022-01-01

Obtenir text complet

Artigo

15

Carregant...

Imidazoline receptor agonists: more than blood pressure reduction?

per D. V. Nebieridze, S. V. Nedogoda
Publicat 2006-04-01

Obtenir text complet

Artigo

16

Carregant...

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

per D. V. Nebieridze, T. V. Kamyshova
Publicat 2015-12-01

Obtenir text complet

Artigo

17

Carregant...

PREVALENCE OF HYPERURICEMIA AMONG PATIENTS WITH METABOLIC SYNDROME: RESULTS OF THE STUDY IN REAL CLINICAL PRACTICE

per D. V. Nebieridze, N. V. Dolgushina
Publicat 2017-12-01

Obtenir text complet

Artigo

18

Carregant...

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2)

per A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze
Publicat 2020-07-01

Obtenir text complet

Artigo

19

Carregant...

IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS?

per A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
Publicat 2017-11-01

Obtenir text complet

Artigo

20

Carregant...

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues

per N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
Publicat 2019-01-01

Obtenir text complet

Artigo

Afineu la vostra cerca